Arnab Basu, MD, MPH, FACP, is an academic genitourinary oncologist focusing in the care of patients with kidney cancer and bladder cancer at the University of Alabama.
Mapping ctDNA Shedding Differences in GU Cancers With MRD Testing
Arnab Basu, MD, MPH, FACP, explains why sensitivity might be higher in urothelial cancer vs other genitourinary cancers.
Exploring High Sensitivity ctDNA Assays in Genitourinary Malignancies
Arnab Basu, MD, MPH, FACP, discusses his research on high sensitivity circulating tumor DNA assays in genitourinary malignancies.
Basu Provides an Overview of MRD GATE RCC
Arnab Basu, MD, MPH, FACP, discusses molecular residual disease-guided adjuvant therapy in patients with renal cell carcinoma, highlighting the rationale and goals of the MRD gate RCC clinical trial.